We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Psychiatric Problems in Chronic Skin Diseases

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00167752
First Posted: September 14, 2005
Last Update Posted: October 26, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University of Wisconsin, Madison
  Purpose
The purpose of this study is to investigate the prevalence of depression, anxiety, and sleep problems in patients with chronic skin diseases in dermatology clinics at the University of Wisconsin Hospital and Clinics.

Condition
Psoriasis Acne Vitiligo Atopic Dermatitis Pruritic Dermatitis

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Quality of Life, Emotional and Sleep Problems in Chronic Skin Diseases

Resource links provided by NLM:


Further study details as provided by University of Wisconsin, Madison:

Study Start Date: December 2002
Primary Completion Date: February 2006 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Subjects suffering from a chronic skin condition that has lasted over six months

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00167752


Sponsors and Collaborators
University of Wisconsin, Madison
Investigators
Principal Investigator: Ladan Mostaghimi, MD University of Wisconsin, Madison
  More Information

Responsible Party: University of Wisconsin, Madison
ClinicalTrials.gov Identifier: NCT00167752     History of Changes
Other Study ID Numbers: 2002-0420
First Submitted: September 11, 2005
First Posted: September 14, 2005
Last Update Posted: October 26, 2016
Last Verified: October 2016

Additional relevant MeSH terms:
Psoriasis
Dermatitis
Dermatitis, Atopic
Eczema
Vitiligo
Skin Diseases
Pruritus
Skin Diseases, Papulosquamous
Skin Diseases, Genetic
Genetic Diseases, Inborn
Skin Diseases, Eczematous
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases
Hypopigmentation
Pigmentation Disorders
Skin Manifestations
Signs and Symptoms